TAMSULOSIN HYDROCHLORIDE

TAMSULOSIN HYDROCHLORIDE was reported 21117 times

TAMSULOSIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR ANASTOMOTIC HAEMORRHAGE 26 0.8667
1 RIGHT ATRIAL HYPERTROPHY 65 0.5909
2 RADIATION INFLAMMATION 37 0.4625
3 CONGENITAL HIATUS HERNIA 80 0.3509
4 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 59 0.3296
5 PERINEAL CYST 21 0.2877
6 VENA CAVA INJURY 24 0.2609
7 PULMONARY VASCULITIS 135 0.2509
8 TOTAL LUNG CAPACITY ABNORMAL 84 0.2159
9 AMAUROSIS FUGAX 218 0.2024
10 CAPILLARITIS 50 0.1812
11 RENAL CYST HAEMORRHAGE 32 0.1416
12 SPIROMETRY ABNORMAL 80 0.1338
13 MITE ALLERGY 72 0.1099
14 STEROID DEPENDENCE 88 0.1002
15 MALIGNANT MELANOMA STAGE 0 20 0.0957
16 CATARRH 85 0.0940
17 BRONCHIAL WALL THICKENING 67 0.0932
18 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 66 0.0900
19 ABDOMINAL WALL HAEMORRHAGE 22 0.0843
20 MYCOTIC ALLERGY 71 0.0830
21 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 24 0.0792
22 VASCULAR COMPRESSION 25 0.0791
23 NEURITIS 121 0.0783
24 DUST ALLERGY 73 0.0744
25 RIGHT VENTRICULAR HYPERTROPHY 65 0.0720
26 CONJUNCTIVITIS ALLERGIC 80 0.0540
27 BRONCHIAL SECRETION RETENTION 67 0.0526
28 BENIGN PROSTATIC HYPERPLASIA 268 0.0518
29 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 15 0.0517
30 BURNS SECOND DEGREE 88 0.0501
31 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 100 0.0490
32 RETROGRADE EJACULATION 38 0.0479
33 OBSTRUCTIVE SLEEP APNOEA SYNDROME 69 0.0473
34 URINARY TRACT DISORDER 210 0.0466
35 DELAYED GRAFT FUNCTION 33 0.0464
36 RESPIRATORY SYMPTOM 129 0.0453
37 MALIGNANT MELANOMA IN SITU 55 0.0444
38 PULMONARY FUNCTION TEST ABNORMAL 68 0.0436
39 MYOGLOBIN BLOOD INCREASED 66 0.0431
40 AORTIC VALVE STENOSIS 69 0.0387
41 BRONCHIECTASIS 258 0.0383
42 HAEMORRHAGIC STROKE 288 0.0368
43 CAROTID ARTERIOSCLEROSIS 38 0.0368
44 INTERVERTEBRAL DISC SPACE NARROWING 27 0.0335
45 OBSTRUCTIVE AIRWAYS DISORDER 335 0.0301
46 AORTIC DILATATION 32 0.0288
47 FORCED EXPIRATORY VOLUME DECREASED 81 0.0286
48 ARTERIOVENOUS FISTULA 14 0.0285
49 RECTAL PROLAPSE 33 0.0273
50 RENAL HAEMATOMA 14 0.0272
51 DIASTOLIC DYSFUNCTION 81 0.0262
52 HYPOPNOEA 89 0.0256
53 NORMOCHROMIC NORMOCYTIC ANAEMIA 77 0.0256
54 RENAL ISCHAEMIA 14 0.0256
55 GENITAL ULCERATION 19 0.0247
56 ALCOHOL POISONING 65 0.0242
57 FULL BLOOD COUNT ABNORMAL 247 0.0233
58 PULMONARY ALVEOLAR HAEMORRHAGE 130 0.0232
59 BRAIN NATRIURETIC PEPTIDE INCREASED 70 0.0227
60 OCULAR DISCOMFORT 250 0.0222
61 ACQUIRED HAEMOPHILIA 22 0.0220
62 NEUROLOGICAL SYMPTOM 121 0.0211
63 GENITAL PAIN 31 0.0210
64 CHEST X-RAY ABNORMAL 64 0.0209
65 RENAL ARTERY STENOSIS 27 0.0196
66 BREATH SOUNDS ABNORMAL 95 0.0192
67 OBSTRUCTION 71 0.0178
68 GENERALISED OEDEMA 219 0.0177
69 PLANTAR FASCIITIS 59 0.0176
70 ACTINIC KERATOSIS 42 0.0162
71 AORTIC ARTERIOSCLEROSIS 41 0.0159
72 PROSTATE INFECTION 15 0.0156
73 EJACULATION FAILURE 31 0.0154
74 ALVEOLITIS 21 0.0149
75 PROSTATOMEGALY 56 0.0142
76 HEAD DISCOMFORT 251 0.0142
77 PRESYNCOPE 333 0.0137
78 HEPATOSPLENOMEGALY 35 0.0136
79 ALTERED STATE OF CONSCIOUSNESS 294 0.0136
80 ARTERIOSCLEROSIS CORONARY ARTERY 89 0.0134
81 RHINITIS 108 0.0134
82 MEAN CELL VOLUME INCREASED 34 0.0132
83 CARDIAC AMYLOIDOSIS 14 0.0127
84 PROSTATITIS 38 0.0125
85 IDIOPATHIC PULMONARY FIBROSIS 48 0.0121
86 PALATAL OEDEMA 15 0.0121
87 PAROSMIA 91 0.0120
88 ARTERIOSCLEROSIS 113 0.0120
89 GINGIVAL PAIN 95 0.0119
90 COMPLICATIONS OF TRANSPLANTED KIDNEY 27 0.0119
91 URINE FLOW DECREASED 28 0.0117
92 MICTURITION URGENCY 133 0.0116
93 EJACULATION DISORDER 33 0.0116
94 VASCULAR PURPURA 16 0.0115
95 VASCULITIS 132 0.0113
96 PULMONARY PAIN 33 0.0113
97 RECTAL TENESMUS 14 0.0112
98 INSULIN-LIKE GROWTH FACTOR INCREASED 16 0.0112
99 PERIPHERAL SENSORIMOTOR NEUROPATHY 14 0.0111
100 PRIAPISM 37 0.0107
101 HAEMATEMESIS 267 0.0105
102 DIVERTICULUM INTESTINAL 46 0.0105
103 HYPERPARATHYROIDISM SECONDARY 26 0.0104
104 TONGUE DRY 14 0.0103
105 CARDIAC MURMUR 89 0.0103
106 DIVERTICULUM INTESTINAL HAEMORRHAGIC 23 0.0102
107 HAEMATURIA 350 0.0102
108 SPINAL STENOSIS 42 0.0102
109 PHOTOPHOBIA 187 0.0099
110 PROSTATIC DISORDER 53 0.0096
111 EYELID PAIN 19 0.0093
112 LEFT VENTRICULAR HYPERTROPHY 40 0.0093
113 NOCTURIA 112 0.0092
114 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 156 0.0092
115 ORTHOSTATIC HYPOTENSION 158 0.0091
116 DIPLOPIA 232 0.0089
117 ESSENTIAL HYPERTENSION 16 0.0087
118 AORTIC VALVE INCOMPETENCE 37 0.0087
119 LACTOSE INTOLERANCE 22 0.0086
120 HYPERCHOLESTEROLAEMIA 82 0.0085
121 BLOOD PRESSURE DIASTOLIC ABNORMAL 21 0.0082
122 ASCITES 242 0.0082
123 URINARY TRACT OBSTRUCTION 19 0.0080
124 INTERVERTEBRAL DISC DEGENERATION 74 0.0080
125 INFUSION SITE DISCHARGE 14 0.0080
126 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 381 0.0079
127 PULMONARY FIBROSIS 151 0.0079
128 HYPERPARATHYROIDISM 16 0.0078
129 DERMAL CYST 19 0.0077
130 URINARY RETENTION 257 0.0077
131 BLOOD PRESSURE SYSTOLIC ABNORMAL 19 0.0077
132 DYSPNOEA EXERTIONAL 287 0.0076
133 TESTICULAR PAIN 24 0.0076
134 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 38 0.0075
135 WHEEZING 438 0.0074
136 VENOUS THROMBOSIS LIMB 15 0.0073
137 SENSATION OF FOREIGN BODY 61 0.0072
138 CARDIO-RESPIRATORY ARREST 299 0.0071
139 PRODUCTIVE COUGH 341 0.0071
140 URINARY HESITATION 17 0.0071
141 SQUAMOUS CELL CARCINOMA OF SKIN 42 0.0069
142 BLADDER SPASM 13 0.0069
143 ATRIOVENTRICULAR BLOCK FIRST DEGREE 30 0.0069
144 TINNITUS 316 0.0069
145 UMBILICAL HERNIA 32 0.0068
146 ARTERIAL DISORDER 13 0.0068
147 SWELLING OF EYELID 42 0.0067
148 ADRENOCORTICAL INSUFFICIENCY ACUTE 13 0.0067
149 DISTRIBUTIVE SHOCK 15 0.0066
150 EYE PAIN 372 0.0066
151 HYPERTONIC BLADDER 19 0.0066
152 SLEEP APNOEA SYNDROME 125 0.0065
153 RENAL CYST 52 0.0065
154 DIZZINESS POSTURAL 63 0.0065
155 FOREIGN BODY IN THROAT 20 0.0063
156 TUBULOINTERSTITIAL NEPHRITIS 117 0.0062
157 EXOSTOSIS 57 0.0062
158 SECRETION DISCHARGE 78 0.0062
159 TROPONIN INCREASED 47 0.0062
160 LARGE INTESTINE POLYP 42 0.0061
161 EOSINOPHILIA 105 0.0060
162 PRODUCT ADMINISTRATION INTERRUPTED 47 0.0060
163 IMPAIRED QUALITY OF LIFE 85 0.0059
164 HAEMOPTYSIS 164 0.0059
165 NODULE 76 0.0058
166 PNEUMOTHORAX 92 0.0058
167 GUILLAIN-BARRE SYNDROME 28 0.0058
168 BLINDNESS 235 0.0058
169 GOUT 103 0.0057
170 ANAL HAEMORRHAGE 16 0.0057
171 CARDIAC FAILURE CHRONIC 24 0.0056
172 ATRIOVENTRICULAR BLOCK 43 0.0056
173 ERECTILE DYSFUNCTION 142 0.0055
174 CUTANEOUS VASCULITIS 20 0.0055
175 INFUSION SITE HAEMORRHAGE 18 0.0055
176 PEMPHIGOID 41 0.0054
177 HALLUCINATION, VISUAL 114 0.0054
178 EMBOLIC STROKE 19 0.0054
179 ORTHOPNOEA 17 0.0053
180 COMA 253 0.0053
181 CORONARY ARTERY DISEASE 159 0.0052
182 DERMATITIS EXFOLIATIVE GENERALISED 18 0.0052
183 WRONG PATIENT RECEIVED PRODUCT 15 0.0051
184 SYNCOPE 512 0.0051
185 INCREASED UPPER AIRWAY SECRETION 26 0.0051
186 HALLUCINATIONS, MIXED 21 0.0050
187 INTRACRANIAL ANEURYSM 20 0.0050
188 NIGHTMARE 171 0.0049
189 DUODENAL ULCER HAEMORRHAGE 14 0.0049
190 DYSURIA 180 0.0049
191 HYPERURICAEMIA 20 0.0049
192 FOOD POISONING 26 0.0048
193 SPINAL OSTEOARTHRITIS 42 0.0048
194 HYPERTHYROIDISM 69 0.0048
195 DECREASED INTEREST 28 0.0047
196 HEPATIC CYTOLYSIS 60 0.0047
197 ADRENAL INSUFFICIENCY 57 0.0047
198 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 48 0.0047
199 HYPOTHYROIDISM 149 0.0047
200 URINARY INCONTINENCE 138 0.0047
201 AORTIC STENOSIS 16 0.0046
202 SEASONAL ALLERGY 65 0.0046
203 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 233 0.0045
204 UROSEPSIS 41 0.0044
205 FREQUENT BOWEL MOVEMENTS 120 0.0044
206 STAPHYLOCOCCAL BACTERAEMIA 19 0.0044
207 CARDIAC FAILURE ACUTE 29 0.0043
208 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 309 0.0043
209 FREEZING PHENOMENON 16 0.0043
210 HYPOXIA 152 0.0043
211 JOINT INJURY 92 0.0043
212 PROSTATIC SPECIFIC ANTIGEN INCREASED 59 0.0043
213 ATRIAL FIBRILLATION 415 0.0043
214 RECTAL HAEMORRHAGE 181 0.0042
215 BLOOD PRESSURE FLUCTUATION 101 0.0042
216 BASAL CELL CARCINOMA 65 0.0042
217 LUNG DISORDER 204 0.0042
218 SOPOR 55 0.0041
219 BLOOD POTASSIUM INCREASED 67 0.0041
220 RED CELL DISTRIBUTION WIDTH INCREASED 17 0.0041
221 IMPAIRED WORK ABILITY 87 0.0041
222 ODYNOPHAGIA 24 0.0040
223 OESOPHAGEAL CANDIDIASIS 16 0.0040
224 SWOLLEN TONGUE 125 0.0040
225 EXERCISE TOLERANCE DECREASED 23 0.0040
226 DELUSION 62 0.0040
227 COVID-19 PNEUMONIA 47 0.0040
228 CORONARY ARTERY STENOSIS 20 0.0040
229 INTERSTITIAL LUNG DISEASE 192 0.0040
230 JAUNDICE CHOLESTATIC 14 0.0040
231 RALES 23 0.0040
232 HYPOMAGNESAEMIA 54 0.0039
233 RESTLESS LEGS SYNDROME 70 0.0038
234 WRONG PRODUCT ADMINISTERED 26 0.0038
235 SEPSIS 428 0.0038
236 INFUSION SITE SWELLING 24 0.0038
237 FOREIGN BODY SENSATION IN EYES 24 0.0038
238 TRANSIENT ISCHAEMIC ATTACK 127 0.0038
239 HOT FLUSH 282 0.0037
240 BLOOD CHOLESTEROL ABNORMAL 17 0.0037
241 VERTIGO 223 0.0037
242 ASTHMA 412 0.0036
243 TASTE DISORDER 73 0.0036
244 SKIN ABRASION 17 0.0036
245 MULTIPLE ALLERGIES 28 0.0036
246 BLOOD PRESSURE DIASTOLIC DECREASED 26 0.0035
247 HAEMOGLOBIN INCREASED 16 0.0035
248 POLLAKIURIA 146 0.0035
249 GASTROOESOPHAGEAL REFLUX DISEASE 280 0.0035
250 DRUG INTERACTION 551 0.0035
251 ENURESIS 14 0.0035
252 TOOTH INJURY 15 0.0035
253 ANAL INCONTINENCE 31 0.0034
254 INFUSION SITE ERYTHEMA 29 0.0034
255 SHOCK HAEMORRHAGIC 28 0.0034
256 DIABETIC NEUROPATHY 17 0.0034
257 ANAL FISTULA 18 0.0034
258 HYPOALBUMINAEMIA 26 0.0033
259 DEMENTIA 93 0.0033
260 TACHYCARDIA 293 0.0033
261 HALLUCINATION 247 0.0033
262 SPUTUM DISCOLOURED 31 0.0033
263 HYPERKERATOSIS 18 0.0033
264 HAEMATOCHEZIA 180 0.0033
265 OXYGEN SATURATION DECREASED 183 0.0033
266 ACCIDENTAL OVERDOSE 119 0.0032
267 RED BLOOD CELL COUNT DECREASED 93 0.0032
268 NEPHROLITHIASIS 149 0.0032
269 SEXUAL DYSFUNCTION 38 0.0032
270 NEPHROGENIC ANAEMIA 15 0.0032
271 HYPERVOLAEMIA 16 0.0032
272 ANGINA UNSTABLE 21 0.0032
273 BLADDER DISORDER 32 0.0032
274 HAEMORRHOIDS 62 0.0032
275 HEPATIC STEATOSIS 59 0.0032
276 BRADYCARDIA 168 0.0032
277 VITAMIN D DECREASED 27 0.0032
278 SUBDURAL HAEMATOMA 45 0.0031
279 SCHIZOPHRENIA 38 0.0031
280 HYPERKALAEMIA 109 0.0031
281 URINE ABNORMALITY 14 0.0031
282 HYDRONEPHROSIS 23 0.0031
283 CEREBRAL INFARCTION 75 0.0031
284 COUGH 857 0.0031
285 PNEUMONIA BACTERIAL 28 0.0030
286 PRE-EXISTING CONDITION IMPROVED 19 0.0030
287 FAECES SOFT 22 0.0030
288 AORTIC ANEURYSM 23 0.0030
289 HYPONATRAEMIA 170 0.0030
290 HYPOTENSION 595 0.0030
291 DYSPHEMIA 13 0.0030
292 ECZEMA 155 0.0030
293 SOMNOLENCE 596 0.0030
294 BRONCHOSPASM 42 0.0029
295 CHOKING SENSATION 16 0.0029
296 C-REACTIVE PROTEIN INCREASED 105 0.0029
297 ON AND OFF PHENOMENON 16 0.0029
298 EMPHYSEMA 29 0.0029
299 HYPOPHOSPHATAEMIA 21 0.0028
300 HEPARIN-INDUCED THROMBOCYTOPENIA 14 0.0028
301 CHILLS 333 0.0028
302 BLOOD PRESSURE INCREASED 434 0.0028
303 DRUG LEVEL ABOVE THERAPEUTIC 13 0.0028
304 ASPIRATION 31 0.0028
305 FEELING DRUNK 21 0.0028
306 FALL 940 0.0028
307 SLEEP DISORDER 199 0.0028
308 CHOLESTASIS 54 0.0028
309 DECREASED APPETITE 649 0.0028
310 UPPER-AIRWAY COUGH SYNDROME 23 0.0028
311 HEART RATE DECREASED 98 0.0028
312 ACUTE KIDNEY INJURY 427 0.0028
313 ERYSIPELAS 14 0.0028
314 LOSS OF LIBIDO 25 0.0028
315 HYPOACUSIS 119 0.0028
316 ATRIAL FLUTTER 22 0.0028
317 INITIAL INSOMNIA 28 0.0027
318 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 24 0.0027
319 MYALGIA 461 0.0027
320 BRADYKINESIA 16 0.0027
321 THROMBOSIS 218 0.0027
322 MEDICATION ERROR 150 0.0027
323 HYPERTENSIVE CRISIS 30 0.0027
324 VISION BLURRED 369 0.0027
325 CONFUSIONAL STATE 431 0.0027
326 PULMONARY EMBOLISM 253 0.0027
327 DYSPNOEA 1506 0.0027
328 ULCER HAEMORRHAGE 18 0.0027
329 PNEUMONIA ASPIRATION 66 0.0026
330 PULMONARY HYPERTENSION 55 0.0026
331 INFUSION SITE PAIN 34 0.0026
332 DIZZINESS 1308 0.0026
333 BLOOD DISORDER 21 0.0026
334 GASTROINTESTINAL MOTILITY DISORDER 14 0.0026
335 ONYCHOCLASIS 18 0.0026
336 SKIN ATROPHY 15 0.0026
337 GLOMERULAR FILTRATION RATE DECREASED 32 0.0026
338 HYPOKALAEMIA 120 0.0026
339 MYOCLONUS 31 0.0026
340 LARYNGEAL OEDEMA 16 0.0026
341 MOUTH HAEMORRHAGE 19 0.0026
342 BEHAVIOUR DISORDER 14 0.0026
343 HERNIA 50 0.0026
344 WEIGHT FLUCTUATION 27 0.0026
345 DECUBITUS ULCER 21 0.0026
346 SKIN LACERATION 28 0.0026
347 SYSTEMIC LUPUS ERYTHEMATOSUS 91 0.0026
348 SPINAL PAIN 30 0.0026
349 COVID-19 449 0.0026
350 SUDDEN DEATH 27 0.0025
351 HAEMATOMA 66 0.0025
352 MELAENA 56 0.0025
353 BLOOD PRESSURE DECREASED 169 0.0025
354 GAMMA-GLUTAMYLTRANSFERASE INCREASED 56 0.0025
355 CIRCULATORY COLLAPSE 43 0.0025
356 URINE OUTPUT DECREASED 22 0.0025
357 SPINAL OPERATION 31 0.0025
358 TENDON PAIN 19 0.0025
359 COLITIS ULCERATIVE 112 0.0025
360 BRAIN FOG 39 0.0025
361 ASTHENIA 933 0.0025
362 OSTEOPOROSIS 102 0.0025
363 LACTIC ACIDOSIS 80 0.0025
364 RESPIRATION ABNORMAL 17 0.0025
365 ERYTHEMA MULTIFORME 23 0.0025
366 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 15 0.0025
367 HEPATITIS ACUTE 16 0.0025
368 OEDEMA PERIPHERAL 300 0.0025
369 POST PROCEDURAL INFECTION 20 0.0025
370 LARGE INTESTINE PERFORATION 17 0.0024
371 DEEP VEIN THROMBOSIS 159 0.0024
372 SPINAL COMPRESSION FRACTURE 20 0.0024
373 BALANCE DISORDER 209 0.0024
374 CHRONIC KIDNEY DISEASE 183 0.0024
375 SKIN FISSURES 47 0.0024
376 PRODUCT DOSE OMISSION IN ERROR 68 0.0024
377 ATRIOVENTRICULAR BLOCK COMPLETE 16 0.0024
378 HYPOCALCAEMIA 45 0.0024
379 GLYCOSYLATED HAEMOGLOBIN INCREASED 60 0.0024
380 DYSPHONIA 139 0.0024
381 KNEE ARTHROPLASTY 50 0.0024
382 HYPERSOMNIA 68 0.0024
383 MUSCLE ATROPHY 30 0.0024
384 GASTROINTESTINAL PAIN 26 0.0024
385 GENERAL PHYSICAL CONDITION ABNORMAL 16 0.0024
386 INSURANCE ISSUE 36 0.0024
387 FLANK PAIN 22 0.0023
388 HOSPICE CARE 23 0.0023
389 OROPHARYNGEAL DISCOMFORT 21 0.0023
390 URINARY TRACT INFECTION 396 0.0023
391 CARDIAC FLUTTER 15 0.0023
392 BLOOD MAGNESIUM DECREASED 20 0.0023
393 DECREASED ACTIVITY 25 0.0023
394 HICCUPS 19 0.0023
395 PANCREATITIS ACUTE 52 0.0023
396 ACUTE MYOCARDIAL INFARCTION 68 0.0023
397 NEURALGIA 56 0.0023
398 INGUINAL HERNIA 14 0.0023
399 HEART RATE IRREGULAR 52 0.0023
400 CHOLECYSTITIS ACUTE 13 0.0023
401 ABNORMAL DREAMS 63 0.0023
402 BLOOD GLUCOSE FLUCTUATION 25 0.0023
403 PRODUCT ADMINISTRATION ERROR 46 0.0023
404 WALKING AID USER 15 0.0023
405 DUODENAL ULCER 16 0.0023
406 INSOMNIA 602 0.0023
407 UPPER GASTROINTESTINAL HAEMORRHAGE 38 0.0023
408 DIVERTICULUM 16 0.0022
409 RIB FRACTURE 46 0.0022
410 ANGINA PECTORIS 64 0.0022
411 SEPTIC SHOCK 97 0.0022
412 MYASTHENIA GRAVIS 18 0.0022
413 HYPOGLYCAEMIA 108 0.0022
414 PULMONARY MASS 33 0.0022
415 CEREBRAL HAEMORRHAGE 79 0.0022
416 CYSTITIS 70 0.0022
417 CATARACT OPERATION 13 0.0022
418 ORAL PAIN 49 0.0022
419 ESCHERICHIA INFECTION 18 0.0022
420 HEAD INJURY 69 0.0022
421 INTENTIONAL DOSE OMISSION 62 0.0022
422 TOXIC EPIDERMAL NECROLYSIS 33 0.0022
423 SINUS BRADYCARDIA 21 0.0022
424 LOSS OF CONSCIOUSNESS 277 0.0022
425 SUBARACHNOID HAEMORRHAGE 22 0.0022
426 NEUTROPHIL COUNT INCREASED 22 0.0021
427 SINUS CONGESTION 29 0.0021
428 NASAL CONGESTION 126 0.0021
429 PALPITATIONS 251 0.0021
430 WHITE BLOOD CELL COUNT INCREASED 82 0.0021
431 OBESITY 34 0.0021
432 DELIRIUM 74 0.0021
433 PNEUMONITIS 58 0.0021
434 CHEST DISCOMFORT 218 0.0021
435 RESPIRATORY TRACT CONGESTION 33 0.0021
436 CARDIAC FAILURE 166 0.0021
437 MUSCULAR WEAKNESS 235 0.0021
438 EJECTION FRACTION DECREASED 32 0.0021
439 PAIN IN EXTREMITY 605 0.0021
440 RESTLESSNESS 75 0.0020
441 ARTHRITIS 161 0.0020
442 PHARYNGEAL SWELLING 20 0.0020
443 HEPATIC FUNCTION ABNORMAL 76 0.0020
444 METABOLIC ACIDOSIS 65 0.0020
445 PSYCHIATRIC SYMPTOM 15 0.0020
446 SCAB 23 0.0020
447 CHOLECYSTITIS 24 0.0020
448 PRURITUS 773 0.0020
449 FATIGUE 1564 0.0020
450 ABDOMINAL PAIN UPPER 411 0.0020
451 DIARRHOEA 1286 0.0020
452 PLEURAL EFFUSION 121 0.0020
453 DEPRESSION 452 0.0020
454 LACRIMATION INCREASED 60 0.0020
455 TOXIC SKIN ERUPTION 20 0.0020
456 ABDOMINAL DISCOMFORT 333 0.0020
457 STENT PLACEMENT 16 0.0020
458 HYPERTENSION 419 0.0020
459 CARDIAC OPERATION 17 0.0020
460 CONSTIPATION 430 0.0020
461 BACK DISORDER 32 0.0020
462 APPETITE DISORDER 13 0.0020
463 NEUTROPENIC SEPSIS 14 0.0020
464 ADVERSE DRUG REACTION 176 0.0020
465 LIPASE INCREASED 15 0.0020
466 BLOOD LACTATE DEHYDROGENASE INCREASED 31 0.0020
467 POLYURIA 16 0.0020
468 RENAL DISORDER 91 0.0020
469 PRODUCT USE IN UNAPPROVED INDICATION 484 0.0020
470 CARDIOMEGALY 24 0.0019
471 COGNITIVE DISORDER 91 0.0019
472 CARDIAC FAILURE CONGESTIVE 156 0.0019
473 PRODUCT DISTRIBUTION ISSUE 18 0.0019
474 GASTROENTERITIS VIRAL 35 0.0019
475 EPISTAXIS 145 0.0019
476 PERSONALITY CHANGE 18 0.0019
477 FULL BLOOD COUNT DECREASED 39 0.0019
478 DERMATITIS BULLOUS 14 0.0019
479 RHINORRHOEA 125 0.0019
480 FEAR 52 0.0019
481 JAUNDICE 52 0.0019
482 NEPHROPATHY 18 0.0019
483 AGEUSIA 48 0.0019
484 RASH PUSTULAR 14 0.0019
485 LIP SWELLING 64 0.0019
486 CONTUSION 185 0.0019
487 INTENTIONAL PRODUCT USE ISSUE 168 0.0019
488 DYSGEUSIA 142 0.0019
489 WEIGHT DECREASED 531 0.0019
490 BLOOD PRESSURE SYSTOLIC INCREASED 37 0.0019
491 NIGHT SWEATS 61 0.0019
492 BLOOD ALKALINE PHOSPHATASE INCREASED 47 0.0019
493 INCONTINENCE 20 0.0019
494 ABDOMINAL PAIN 440 0.0019
495 DEVICE DISLOCATION 82 0.0019
496 SKIN EXFOLIATION 159 0.0019
497 ANAEMIA 356 0.0019
498 BREAST TENDERNESS 14 0.0019
499 BLOOD SODIUM DECREASED 35 0.0019
500 DEPRESSED MOOD 98 0.0019
501 PNEUMONIA 597 0.0018
502 SKIN SWELLING 16 0.0018
503 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 332 0.0018
504 ABNORMAL FAECES 15 0.0018
505 PLATELET COUNT DECREASED 195 0.0018
506 BLOOD POTASSIUM DECREASED 55 0.0018
507 BOWEL MOVEMENT IRREGULARITY 14 0.0018
508 MIDDLE INSOMNIA 34 0.0018
509 SCIATICA 29 0.0018
510 SINUS DISORDER 36 0.0018
511 PERIPHERAL SWELLING 280 0.0018
512 BLISTER 102 0.0018
513 ACUTE CORONARY SYNDROME 15 0.0018
514 CONDITION AGGRAVATED 549 0.0018
515 HEMIPLEGIA 15 0.0018
516 ROTATOR CUFF SYNDROME 23 0.0018
517 SKIN INFECTION 20 0.0018
518 PYREXIA 616 0.0018
519 FACE OEDEMA 30 0.0018
520 PRODUCT USE COMPLAINT 28 0.0018
521 EXPOSURE VIA SKIN CONTACT 46 0.0018
522 ARTHRALGIA 738 0.0018
523 RHABDOMYOLYSIS 74 0.0018
524 OEDEMA 96 0.0018
525 MITRAL VALVE INCOMPETENCE 20 0.0018
526 TRICUSPID VALVE INCOMPETENCE 14 0.0018
527 BLOOD PRESSURE ABNORMAL 35 0.0018
528 LIVER DISORDER 78 0.0018
529 PRODUCT DOSE OMISSION ISSUE 516 0.0018
530 DRUG EFFECT LESS THAN EXPECTED 26 0.0018
531 END STAGE RENAL DISEASE 32 0.0018
532 PSEUDOMONAS INFECTION 15 0.0017
533 PULMONARY CONGESTION 23 0.0017
534 HAEMOGLOBIN DECREASED 179 0.0017
535 SKIN ULCER 45 0.0017
536 PARANOIA 30 0.0017
537 IRON DEFICIENCY ANAEMIA 16 0.0017
538 VENTRICULAR EXTRASYSTOLES 18 0.0017
539 BLOOD UREA INCREASED 29 0.0017
540 DYSARTHRIA 65 0.0017
541 DISORIENTATION 68 0.0017
542 BLOOD CREATININE INCREASED 112 0.0017
543 APATHY 25 0.0017
544 GROIN PAIN 15 0.0017
545 SPLENOMEGALY 20 0.0017
546 RENAL IMPAIRMENT 143 0.0017
547 LYMPHOCYTE COUNT DECREASED 30 0.0017
548 LIMB INJURY 46 0.0017
549 FLATULENCE 96 0.0017
550 ILEUS 21 0.0017
551 SKIN HAEMORRHAGE 25 0.0017
552 BLOOD URINE PRESENT 32 0.0017
553 GYNAECOMASTIA 52 0.0017
554 MUSCULOSKELETAL CHEST PAIN 26 0.0017
555 CORONARY ARTERY OCCLUSION 23 0.0017
556 POOR QUALITY SLEEP 36 0.0017
557 TOOTH ABSCESS 17 0.0017
558 EYE IRRITATION 96 0.0017
559 ACUTE RESPIRATORY FAILURE 32 0.0017
560 CARDIAC DISORDER 155 0.0017
561 LOCALISED INFECTION 40 0.0017
562 FLUID RETENTION 84 0.0016
563 ARRHYTHMIA 78 0.0016
564 MALAISE 722 0.0016
565 METASTASES TO LUNG 19 0.0016
566 CHOKING 32 0.0016
567 CHROMATURIA 37 0.0016
568 STAPHYLOCOCCAL INFECTION 54 0.0016
569 DRUG ERUPTION 29 0.0016
570 EYE DISCHARGE 17 0.0016
571 ILLNESS 168 0.0016
572 SWELLING FACE 106 0.0016
573 DRUG-INDUCED LIVER INJURY 51 0.0016
574 RESPIRATORY FAILURE 118 0.0016
575 LETHARGY 93 0.0016
576 PROSTATE CANCER 130 0.0016
577 HAEMATOCRIT DECREASED 32 0.0016
578 HEADACHE 1007 0.0016
579 RENAL PAIN 17 0.0016
580 RASH MACULAR 56 0.0016
581 BLOOD IRON DECREASED 19 0.0016
582 PERICARDIAL EFFUSION 37 0.0016
583 BLOOD CREATINE PHOSPHOKINASE INCREASED 46 0.0016
584 DEHYDRATION 213 0.0016
585 TUMOUR LYSIS SYNDROME 14 0.0016
586 CONTRAINDICATED PRODUCT ADMINISTERED 48 0.0016
587 POISONING DELIBERATE 15 0.0016
588 LUNG NEOPLASM MALIGNANT 65 0.0016
589 PALLOR 43 0.0016
590 INTERNATIONAL NORMALISED RATIO INCREASED 45 0.0016
591 FEEDING DISORDER 32 0.0016
592 DRY MOUTH 128 0.0016
593 DRY THROAT 16 0.0016
594 RASH MACULO-PAPULAR 35 0.0016
595 EYE INFLAMMATION 15 0.0016
596 ULCER 25 0.0016
597 SLUGGISHNESS 16 0.0016
598 FEBRILE NEUTROPENIA 104 0.0016
599 THIRST 28 0.0016
600 SUPRAVENTRICULAR TACHYCARDIA 15 0.0016
601 GASTRIC HAEMORRHAGE 18 0.0016
602 BACK INJURY 17 0.0016
603 GASTROINTESTINAL INFECTION 14 0.0016
604 CATARACT 93 0.0016
605 SENSORY DISTURBANCE 25 0.0016
606 THERAPY NON-RESPONDER 70 0.0016
607 GAIT INABILITY 52 0.0016
608 GAIT DISTURBANCE 297 0.0016
609 ELECTROLYTE IMBALANCE 18 0.0015
610 MUSCLE SPASTICITY 19 0.0015
611 OSTEOMYELITIS 28 0.0015
612 DYSSTASIA 45 0.0015
613 CANDIDA INFECTION 26 0.0015
614 RESPIRATORY TRACT INFECTION 40 0.0015
615 RASH PRURITIC 83 0.0015
616 MOBILITY DECREASED 110 0.0015
617 RENAL FAILURE 203 0.0015
618 BLOOD TRIGLYCERIDES INCREASED 27 0.0015
619 BODY TEMPERATURE DECREASED 15 0.0015
620 MUSCLE SPASMS 279 0.0015
621 ANXIETY 432 0.0015
622 HYPOKINESIA 22 0.0015
623 CEREBROVASCULAR ACCIDENT 256 0.0015
624 MUSCULOSKELETAL DISCOMFORT 26 0.0015
625 MACULAR DEGENERATION 18 0.0015
626 HYPERLIPIDAEMIA 18 0.0015
627 EYE INFECTION 17 0.0015
628 HIP FRACTURE 48 0.0015
629 ANGIOEDEMA 66 0.0015
630 GASTROINTESTINAL HAEMORRHAGE 124 0.0015
631 PAIN IN JAW 42 0.0015
632 NEOPLASM 17 0.0015
633 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 38 0.0015
634 WHITE BLOOD CELL COUNT DECREASED 160 0.0015
635 FAECES DISCOLOURED 32 0.0015
636 NASOPHARYNGITIS 272 0.0015
637 COLD SWEAT 26 0.0015
638 THERAPY PARTIAL RESPONDER 23 0.0015
639 HIATUS HERNIA 19 0.0015
640 NECK PAIN 82 0.0015
641 BLOOD GLUCOSE ABNORMAL 27 0.0015
642 HYPOAESTHESIA ORAL 22 0.0015
643 FACIAL PAIN 13 0.0015
644 NEUTROPENIA 198 0.0015
645 OCULAR HYPERAEMIA 69 0.0015
646 PHOTOSENSITIVITY REACTION 24 0.0015
647 OROPHARYNGEAL PAIN 134 0.0014
648 PSYCHOMOTOR HYPERACTIVITY 24 0.0014
649 DIVERTICULITIS 40 0.0014
650 TENDERNESS 15 0.0014
651 TOOTH DISORDER 32 0.0014
652 PETECHIAE 15 0.0014
653 TOOTHACHE 26 0.0014
654 PARKINSONISM 14 0.0014
655 ATAXIA 17 0.0014
656 DERMATITIS ALLERGIC 18 0.0014
657 SNEEZING 32 0.0014
658 NEUROTOXICITY 25 0.0014
659 MEMORY IMPAIRMENT 196 0.0014
660 THROAT IRRITATION 64 0.0014
661 TYPE 2 DIABETES MELLITUS 48 0.0014
662 LABORATORY TEST ABNORMAL 42 0.0014
663 NEUROPATHY PERIPHERAL 135 0.0014
664 HEMIPARESIS 24 0.0014
665 ASPARTATE AMINOTRANSFERASE INCREASED 75 0.0014
666 SINUS TACHYCARDIA 20 0.0014
667 DRY EYE 70 0.0014
668 CONJUNCTIVITIS 26 0.0014
669 DYSPHAGIA 133 0.0014
670 IRRITABLE BOWEL SYNDROME 30 0.0014
671 TREMOR 231 0.0014
672 DISTURBANCE IN ATTENTION 75 0.0014
673 ELECTROCARDIOGRAM QT PROLONGED 50 0.0014
674 ARTHROPATHY 77 0.0014
675 LOWER RESPIRATORY TRACT INFECTION 63 0.0014
676 PULMONARY OEDEMA 62 0.0014
677 SMALL INTESTINAL OBSTRUCTION 17 0.0014
678 PLATELET COUNT INCREASED 18 0.0014
679 RASH 601 0.0014
680 KIDNEY INFECTION 27 0.0014
681 MUCOSAL INFLAMMATION 36 0.0014
682 THERAPY INTERRUPTED 98 0.0014
683 GASTRITIS 36 0.0014
684 PROTEINURIA 26 0.0014
685 TOOTH INFECTION 18 0.0014
686 INFLUENZA 152 0.0014
687 SARS-COV-2 TEST POSITIVE 18 0.0014
688 INFLAMMATION 70 0.0014
689 LYMPHADENOPATHY 48 0.0014
690 SPEECH DISORDER 71 0.0014
691 DYSKINESIA 55 0.0014
692 LIVER INJURY 33 0.0013
693 PRODUCT PRESCRIBING ERROR 32 0.0013
694 COLON CANCER 20 0.0013
695 THINKING ABNORMAL 25 0.0013
696 LIVER FUNCTION TEST ABNORMAL 39 0.0013
697 MIGRAINE 128 0.0013
698 BACTERIAL INFECTION 25 0.0013
699 BACK PAIN 311 0.0013
700 MUSCLE RIGIDITY 16 0.0013
701 NEPHROPATHY TOXIC 15 0.0013
702 JOINT STIFFNESS 35 0.0013
703 BLOOD CALCIUM DECREASED 15 0.0013
704 DRY SKIN 178 0.0013
705 BLOOD CHOLESTEROL INCREASED 62 0.0013
706 FEELING COLD 37 0.0013
707 SCRATCH 14 0.0013
708 BRONCHITIS 98 0.0013
709 THERAPEUTIC RESPONSE DECREASED 80 0.0013
710 OSTEOPENIA 20 0.0013
711 PRODUCT AVAILABILITY ISSUE 30 0.0013
712 DERMATITIS CONTACT 15 0.0013
713 GENERAL PHYSICAL HEALTH DETERIORATION 152 0.0013
714 CELLULITIS 66 0.0013
715 CYTOPENIA 16 0.0013
716 ANGER 44 0.0013
717 GLAUCOMA 25 0.0013
718 BEDRIDDEN 17 0.0013
719 ORAL CANDIDIASIS 17 0.0013
720 EYE SWELLING 48 0.0013
721 HEART RATE INCREASED 127 0.0013
722 MENTAL IMPAIRMENT 31 0.0013
723 SKIN LESION 35 0.0013
724 DYSPEPSIA 125 0.0013
725 EAR DISCOMFORT 13 0.0013
726 THERAPEUTIC RESPONSE SHORTENED 42 0.0013
727 ABDOMINAL DISTENSION 132 0.0013
728 MENTAL STATUS CHANGES 35 0.0013
729 BLOOD BILIRUBIN INCREASED 34 0.0013
730 APHASIA 38 0.0013
731 SKIN CANCER 27 0.0013
732 MALNUTRITION 14 0.0013
733 PULMONARY ARTERIAL HYPERTENSION 18 0.0012
734 PERIPHERAL COLDNESS 17 0.0012
735 SURGERY 72 0.0012
736 ORAL DISCOMFORT 17 0.0012
737 OFF LABEL USE 1070 0.0012
738 CARDIOVASCULAR DISORDER 31 0.0012
739 ACUTE MYELOID LEUKAEMIA 19 0.0012
740 BODY HEIGHT DECREASED 13 0.0012
741 CHEST PAIN 225 0.0012
742 MOVEMENT DISORDER 39 0.0012
743 CARPAL TUNNEL SYNDROME 17 0.0012
744 RASH ERYTHEMATOUS 58 0.0012
745 UPPER RESPIRATORY TRACT INFECTION 56 0.0012
746 GENERALISED TONIC-CLONIC SEIZURE 20 0.0012
747 ANAPHYLACTIC SHOCK 31 0.0012
748 HERPES ZOSTER 69 0.0012
749 HEPATOCELLULAR INJURY 17 0.0012
750 SPINAL FRACTURE 24 0.0012
751 CYTOKINE RELEASE SYNDROME 24 0.0012
752 METASTASES TO LIVER 21 0.0012
753 GASTROINTESTINAL DISORDER 107 0.0012
754 PRESCRIBED OVERDOSE 23 0.0012
755 DEVICE MALFUNCTION 83 0.0012
756 NEUROLEPTIC MALIGNANT SYNDROME 14 0.0012
757 HYPERGLYCAEMIA 43 0.0012
758 BACTERAEMIA 14 0.0012
759 OSTEOARTHRITIS 50 0.0012
760 DENTAL CARIES 13 0.0012
761 HYPOPHAGIA 30 0.0012
762 ALANINE AMINOTRANSFERASE INCREASED 72 0.0012
763 HYPERHIDROSIS 151 0.0012
764 STOMATITIS 71 0.0012
765 CENTRAL NERVOUS SYSTEM LESION 16 0.0012
766 LIMB DISCOMFORT 36 0.0012
767 TENDONITIS 18 0.0012
768 PRODUCT DISPENSING ERROR 25 0.0011
769 COORDINATION ABNORMAL 16 0.0011
770 APHONIA 16 0.0011
771 PANCYTOPENIA 64 0.0011
772 MASS 16 0.0011
773 NAUSEA 905 0.0011
774 MOOD ALTERED 31 0.0011
775 RESPIRATORY DISORDER 34 0.0011
776 HYPERCALCAEMIA 14 0.0011
777 SKIN DISCOLOURATION 52 0.0011
778 AGRANULOCYTOSIS 21 0.0011
779 RETCHING 24 0.0011
780 HYPOAESTHESIA 168 0.0011
781 BLOOD COUNT ABNORMAL 17 0.0011
782 ISCHAEMIC STROKE 20 0.0011
783 QUALITY OF LIFE DECREASED 15 0.0011
784 PARALYSIS 16 0.0011
785 DEPRESSED LEVEL OF CONSCIOUSNESS 44 0.0011
786 IMPAIRED GASTRIC EMPTYING 15 0.0011
787 ROAD TRAFFIC ACCIDENT 46 0.0011
788 MANIA 18 0.0011
789 VOMITING 513 0.0011
790 LOCAL SWELLING 19 0.0011
791 SINUSITIS 111 0.0011
792 THROMBOCYTOPENIA 121 0.0011
793 PROCEDURAL PAIN 30 0.0011
794 DERMATITIS ATOPIC 57 0.0011
795 FUNGAL INFECTION 36 0.0011
796 ACUTE RESPIRATORY DISTRESS SYNDROME 19 0.0011
797 PARAESTHESIA 169 0.0011
798 LIVER FUNCTION TEST INCREASED 23 0.0011
799 DEAFNESS 28 0.0011
800 BLOOD TEST ABNORMAL 15 0.0011
801 FEELING ABNORMAL 255 0.0011
802 HAEMORRHAGE 111 0.0011
803 HOSPITALISATION 163 0.0011
804 LYMPHOPENIA 15 0.0011
805 ENCEPHALOPATHY 26 0.0011
806 DIALYSIS 15 0.0011
807 NEUTROPHIL COUNT DECREASED 43 0.0011
808 MALIGNANT NEOPLASM PROGRESSION 108 0.0011
809 INTERVERTEBRAL DISC PROTRUSION 23 0.0011
810 MUSCLE TIGHTNESS 17 0.0010
811 GASTRIC DISORDER 36 0.0010
812 MALIGNANT MELANOMA 14 0.0010
813 HIP ARTHROPLASTY 16 0.0010
814 INFECTION 151 0.0010
815 PRODUCT SUBSTITUTION ISSUE 60 0.0010
816 POST PROCEDURAL COMPLICATION 20 0.0010
817 DEVICE RELATED INFECTION 16 0.0010
818 INTESTINAL OBSTRUCTION 39 0.0010
819 EYE DISORDER 34 0.0010
820 ERUCTATION 20 0.0010
821 EATING DISORDER 22 0.0010
822 PAIN 634 0.0010
823 GASTROENTERITIS 15 0.0010
824 DRUG LEVEL INCREASED 17 0.0010
825 RASH PAPULAR 23 0.0010
826 TREATMENT NONCOMPLIANCE 56 0.0010
827 AGITATION 75 0.0010
828 MUSCULOSKELETAL STIFFNESS 89 0.0010
829 THERAPEUTIC RESPONSE UNEXPECTED 45 0.0010
830 VISUAL IMPAIRMENT 124 0.0010
831 PRODUCT USE ISSUE 188 0.0010
832 IRRITABILITY 60 0.0010
833 DEVICE OCCLUSION 14 0.0010
834 LEUKOCYTOSIS 18 0.0010
835 DISSEMINATED INTRAVASCULAR COAGULATION 14 0.0010
836 SWELLING 93 0.0010
837 VIRAL INFECTION 33 0.0010
838 DIABETES MELLITUS 75 0.0010
839 EYE PRURITUS 33 0.0010
840 BODY TEMPERATURE INCREASED 20 0.0010
841 FEELING HOT 60 0.0010
842 SEIZURE 113 0.0010
843 RENAL INJURY 29 0.0010
844 CHOLELITHIASIS 32 0.0010
845 DEVICE USE ISSUE 17 0.0010
846 INTENTIONAL PRODUCT MISUSE 85 0.0010
847 ANOSMIA 14 0.0010
848 CLOSTRIDIUM DIFFICILE INFECTION 21 0.0010
849 NEOPLASM MALIGNANT 64 0.0010
850 HEPATIC CIRRHOSIS 18 0.0010
851 WEIGHT INCREASED 214 0.0010
852 PRESCRIBED UNDERDOSE 19 0.0010
853 DISEASE PROGRESSION 112 0.0009
854 FEELING JITTERY 18 0.0009
855 INCREASED APPETITE 18 0.0009
856 INTENTIONAL SELF-INJURY 19 0.0009
857 IMMUNODEFICIENCY 14 0.0009
858 HEPATIC ENZYME INCREASED 64 0.0009
859 ERYTHEMA 192 0.0009
860 LEUKOPENIA 46 0.0009
861 JOINT SWELLING 111 0.0009
862 ANHEDONIA 24 0.0009
863 VENTRICULAR TACHYCARDIA 15 0.0009
864 COAGULOPATHY 15 0.0009
865 SKIN DISORDER 30 0.0009
866 MUSCULOSKELETAL PAIN 47 0.0009
867 COLITIS 34 0.0009
868 WOUND 25 0.0009
869 GLOSSODYNIA 20 0.0009
870 PRODUCT PHYSICAL ISSUE 18 0.0009
871 CYANOSIS 14 0.0009
872 HALLUCINATION, AUDITORY 14 0.0009
873 MOOD SWINGS 28 0.0009
874 HYPERSENSITIVITY 163 0.0009
875 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 15 0.0009
876 PRODUCT PRESCRIBING ISSUE 19 0.0009
877 RENAL FAILURE ACUTE 37 0.0009
878 RESPIRATORY DISTRESS 24 0.0009
879 AMNESIA 56 0.0009
880 CARDIAC ARREST 71 0.0009
881 INFUSION RELATED REACTION 57 0.0009
882 HEPATITIS 22 0.0009
883 NEEDLE ISSUE 25 0.0009
884 STEVENS-JOHNSON SYNDROME 19 0.0009
885 DEATH 736 0.0009
886 MOUTH ULCERATION 18 0.0009
887 ADVERSE EVENT 78 0.0008
888 GASTRIC ULCER 16 0.0008
889 GALLBLADDER DISORDER 15 0.0008
890 ANKLE FRACTURE 13 0.0008
891 AGGRESSION 42 0.0008
892 MULTIPLE SCLEROSIS 40 0.0008
893 ABNORMAL BEHAVIOUR 33 0.0008
894 INCORRECT DOSE ADMINISTERED 190 0.0008
895 MYOCARDIAL INFARCTION 145 0.0008
896 EAR PAIN 16 0.0008
897 SUICIDAL IDEATION 75 0.0008
898 BLOOD GLUCOSE INCREASED 154 0.0008
899 BURNING SENSATION 57 0.0008
900 MULTIPLE ORGAN DYSFUNCTION SYNDROME 23 0.0008
901 DERMATITIS 17 0.0008
902 DRUG INTOLERANCE 78 0.0008
903 FLUSHING 82 0.0008
904 MENTAL DISORDER 35 0.0008
905 DRUG ABUSE 66 0.0008
906 DIABETES MELLITUS INADEQUATE CONTROL 14 0.0008
907 EPILEPSY 24 0.0008
908 URTICARIA 131 0.0008
909 PAIN OF SKIN 21 0.0008
910 DRUG INEFFECTIVE 1024 0.0008
911 UNRESPONSIVE TO STIMULI 20 0.0008
912 INFLUENZA LIKE ILLNESS 63 0.0008
913 OVERDOSE 165 0.0008
914 INTENTIONAL OVERDOSE 49 0.0008
915 EAR INFECTION 20 0.0008
916 ABDOMINAL PAIN LOWER 19 0.0008
917 PANIC ATTACK 27 0.0007
918 THERAPY CESSATION 38 0.0007
919 MUSCULOSKELETAL DISORDER 14 0.0007
920 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 17 0.0007
921 TRANSAMINASES INCREASED 16 0.0007
922 BONE PAIN 42 0.0007
923 DIABETIC KETOACIDOSIS 17 0.0007
924 ANAPHYLACTIC REACTION 39 0.0007
925 IMPAIRED HEALING 23 0.0007
926 PANCREATITIS 37 0.0007
927 HEPATIC FAILURE 21 0.0007
928 NEOPLASM PROGRESSION 24 0.0007
929 SEDATION 18 0.0007
930 FRACTURE 13 0.0007
931 PRODUCT PREPARATION ERROR 14 0.0007
932 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 138 0.0007
933 UNDERDOSE 49 0.0007
934 PANCREATIC CARCINOMA 19 0.0007
935 SHOCK 15 0.0007
936 DISEASE RECURRENCE 31 0.0007
937 PSYCHOTIC DISORDER 19 0.0006
938 MULTIPLE SCLEROSIS RELAPSE 43 0.0006
939 ILL-DEFINED DISORDER 38 0.0006
940 THERAPEUTIC PRODUCT EFFECT DECREASED 28 0.0006
941 DISCOMFORT 38 0.0006
942 INJECTION SITE RASH 19 0.0006
943 COMPLETED SUICIDE 51 0.0006
944 OSTEONECROSIS OF JAW 15 0.0006
945 VISUAL ACUITY REDUCED 20 0.0006
946 SUICIDE ATTEMPT 36 0.0006
947 EXTRA DOSE ADMINISTERED 24 0.0006
948 EMOTIONAL DISORDER 18 0.0006
949 ACCIDENTAL EXPOSURE TO PRODUCT 60 0.0006
950 PRODUCT DOSE OMISSION 38 0.0006
951 RHEUMATOID ARTHRITIS 66 0.0006
952 BLADDER CANCER 34 0.0006
953 UNEVALUABLE EVENT 42 0.0006
954 DEVICE ISSUE 49 0.0005
955 NERVOUS SYSTEM DISORDER 17 0.0005
956 BLOOD GLUCOSE DECREASED 26 0.0005
957 INJECTION SITE PAIN 163 0.0005
958 INJECTION SITE BRUISING 42 0.0005
959 ABASIA 13 0.0005
960 EXTRAPYRAMIDAL DISORDER 13 0.0005
961 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 28 0.0005
962 INJECTION SITE SWELLING 39 0.0005
963 RESPIRATORY ARREST 14 0.0005
964 EXPOSURE DURING PREGNANCY 31 0.0005
965 NERVOUSNESS 26 0.0005
966 TARDIVE DYSKINESIA 14 0.0005
967 PLASMA CELL MYELOMA 19 0.0005
968 TOXICITY TO VARIOUS AGENTS 82 0.0005
969 FEMUR FRACTURE 15 0.0005
970 INJECTION SITE MASS 17 0.0005
971 EXPIRED PRODUCT ADMINISTERED 14 0.0004
972 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 29 0.0004
973 INJECTION SITE ERYTHEMA 45 0.0004
974 CRYING 13 0.0004
975 INJURY 25 0.0004
976 PSORIASIS 46 0.0004
977 ALOPECIA 69 0.0004
978 NO ADVERSE EVENT 61 0.0003
979 INJECTION SITE HAEMORRHAGE 24 0.0003
980 CONVULSION 17 0.0003
981 PRODUCT STORAGE ERROR 26 0.0003
982 RENAL CANCER 14 0.0003
983 FOETAL EXPOSURE DURING PREGNANCY 23 0.0003
984 ACNE 21 0.0003
985 PRODUCT QUALITY ISSUE 37 0.0003
986 INJECTION SITE PRURITUS 18 0.0003
987 SKIN BURNING SENSATION 18 0.0003
988 EMOTIONAL DISTRESS 30 0.0002
989 DRUG DOSE OMISSION 38 0.0002
990 DRUG WITHDRAWAL SYNDROME 17 0.0002
991 TREATMENT FAILURE 14 0.0002
992 DRUG DEPENDENCE 18 0.0001